Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Heparin

Heparin-induced thrombocytopenia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Rollin J, et al. Usefulness of 1E12, et al. Monoclonal Anti-Platelet Factor 4 Antibody to Improve Diagnosis of Vaccine-Induced Immune Thrombotic Thrombocytopenia. Research and Practice in Thrombosis and Haemostasis 7 (Suppl. 2): 184-185 abstr. OC 42.4, Oct 2023. Available from: URL: https://dx.doi.org/10.1016/j.rpth.2023.100536 [abstract] Rollin J, et al. Usefulness of 1E12, et al. Monoclonal Anti-Platelet Factor 4 Antibody to Improve Diagnosis of Vaccine-Induced Immune Thrombotic Thrombocytopenia. Research and Practice in Thrombosis and Haemostasis 7 (Suppl. 2): 184-185 abstr. OC 42.4, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​rpth.​2023.​100536 [abstract]
Metadaten
Titel
Heparin
Heparin-induced thrombocytopenia
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54081-6

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Palbociclib

Case report

Antineoplastics

Case report

Deferasirox